Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Berenson

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cancer|November 15, 1997
Bisphosphonates in multiple myelomaJ R Berenson
Current Treatment Options in Oncology|June 12, 2002
Bone disease in myelomaJ R Berenson
Seminars in Oncology|May 11, 2001
Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trialsJ R Berenson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 5, 2002
Advances in the biology and treatment of myeloma bone diseaseJ R Berenson
Seminars in Oncology|October 21, 1999
Etiology of multiple myeloma: what's newJ R Berenson
Medizinische Klinik (Munich, Germany : 1983)|November 23, 2000
Myeloma--the therapeutic challengeJ R Berenson
Seminars in Hematology|April 20, 2001
New advances in the biology and treatment of myeloma bone diseaseJ R Berenson
Oncology (Williston Park, N.Y.)|December 3, 1998
Use of bisphosphonates in patients with metastatic bone diseaseJ R Berenson, A Lipton
Annual Review of Medicine|March 12, 1999
Bisphosphonates in the treatment of malignant bone diseaseJ R Berenson, A Lipton
Drugs & Aging|May 13, 1999
Bisphosphonate treatment of lytic bone metastasesA Lipton, J R Berenson
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cancer|November 15, 1997
Bisphosphonates in multiple myelomaJ R Berenson
Current Treatment Options in Oncology|June 12, 2002
Bone disease in myelomaJ R Berenson
Seminars in Oncology|May 11, 2001
Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trialsJ R Berenson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 5, 2002
Advances in the biology and treatment of myeloma bone diseaseJ R Berenson
Seminars in Oncology|October 21, 1999
Etiology of multiple myeloma: what's newJ R Berenson
Medizinische Klinik (Munich, Germany : 1983)|November 23, 2000
Myeloma--the therapeutic challengeJ R Berenson
Seminars in Hematology|April 20, 2001
New advances in the biology and treatment of myeloma bone diseaseJ R Berenson
Oncology (Williston Park, N.Y.)|December 3, 1998
Use of bisphosphonates in patients with metastatic bone diseaseJ R Berenson, A Lipton
Annual Review of Medicine|March 12, 1999
Bisphosphonates in the treatment of malignant bone diseaseJ R Berenson, A Lipton
Drugs & Aging|May 13, 1999
Bisphosphonate treatment of lytic bone metastasesA Lipton, J R Berenson
Pageof 7